1. Add the LINE friend
2. Send your linking code
Copy your linking code and send it on the Taiwan stocks - Winvest LINE channel
Wait for LINE to confirm that linking is complete
CBT 1595
Close
60.8
▼ 3.6 (−5.59%)
Four-Light Health Check
Overall score
51/ 100
- 📈 Fundamentals 🟢 Strong Same as yesterday
- 👁 Flows 🟡 Neutral Same as yesterday
- 📊 Technicals 🟡 Neutral Same as yesterday
- 💰 Valuation 🔴 Weak Same as yesterday
💡 Worth noting today
No new light or technical changes today. Scroll down for the full four-light check and technical indicators.
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
Don't want to wait until tomorrow? Upgrade to VIP and unlock this full analysis now
VIP has no ticker limit: every health-check factor, valuation river charts and full sector health rankings
CBT (1595) Four-Light Health Check
Loading…
Health check data is being prepared. Please check back later.
The health check data format is being updated. Please check back later.
💡 In one line: ()
Weighting：📈 Fundamentals %｜👁 Flows %｜📊 Technical %｜💰 Valuation %
CBT (1595)
Overall health score / 100
Four-light detail
- 📈 Fundamentals -
- VIP
-
-
｜
- 👁 Flows -
- VIP
-
-
｜
- 📊 Technicals -
- VIP
-
-
｜
- 💰 Valuation -
- VIP
-
-
｜
The underlying four-light factors are VIP content
VIP shows the actual value, rule and note of every factor, with no daily limit.
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
Data as of: ｜This site is not a licensed securities investment consultancy. The four lights are a statistical summary of public information and do not constitute investment advice.
CBT (1595) Technical indicators
- Open 64.6
- High 65.9
- Low 60.8
- Close 60.8
- Volume 561
- Prev close 64.4
CBT (1595) today trades below the 5-day MA, 20-day (monthly) MA and 60-day (quarterly) MA. The MACD histogram stays negative but is narrowing, KD is 27 and leans bearish, RSI is 39 with soft short-term momentum.
Signals today
- ● MACD keeps a negative histogram
Indicator values
| Item | Value |
|---|---|
| Close | 60.80 |
| 5-day MA | 62.38 |
| 20-day (monthly) MA | 70.84 |
| 60-day (quarterly) MA | 69.32 |
| 120-day (half-yearly) MA | 70.53 |
| 240-day (yearly) MA | 58.60 |
| K (9) | 26.52 |
| D (9) | 24.02 |
| RSI (14) | 39.19 |
| Bollinger upper band (20) | 83.69 |
| Bollinger lower band (20) | 57.98 |
| DIF (12,26) | -2.75 |
| MACD (9) | -1.32 |
| OSC histogram | -1.43 |
| Volume (lots) | 561 |
| 20-day avg. volume (lots) | 1,384 |
| Volume ratio (volume ÷ 20-day avg.) | 0.41 |
Indicator
CBT (1595) Monthly revenue
Latest revenue for 10/2026 was NT$110.90M, MoM +30.3%, YoY +23.08%.Cumulative revenue through 10/2026 was NT$806.92M, cumulative YoY +35.78%.
Full-year 2025 revenue was NT$716.17M.
| Month | Close | Revenue (NT$M) | MoM change | YoY change | YTD vs. same period last year |
|---|---|---|---|---|---|
| Month | Close | Revenue (NT$M) | MoM change | YoY change | YTD vs. same period last year |
Latest revenue note:
A professional algo-trading development team at your service
CBT (1595) EPS
Latest EPS for Q2 2026 was NT$-0.24, QoQ +68%, YoY +77%.Cumulative EPS through Q2 2026 was NT$-0.98, YoY -30%.
Full-year 2025 EPS was NT$-1.95.
Income statement
| Year / quarter | Close | Revenue (NT$M) | Gross profit | Operating income | Net income | EPS |
|---|
CBT (1595) Profitability
ROE / ROA (%)
| Year / quarter | Close | Quarterly ROE | Trailing 4Q ROE | Quarterly ROA | Trailing 4Q ROA |
|---|
CBT (1595) — is it a buy?
P/E river chart
The P/E river chart is a valuation tool best suited to companies with stable earnings.Rising river: earnings power is steadily improving.
Flat river: earnings power is relatively stable.
Falling river: earnings power is deteriorating.
The chart splits P/E into three bands: red, yellow and blue.
The company generated no earnings over the past year, so the P/E ratio is not a suitable way to value this stock
The P/E river chart is VIP content
Unlock to see the last 5 years of the P/E river chart
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
P/B river chart
The P/B river chart is a valuation tool best suited to companies with unstable earnings, such as cyclicals.Rising river: book value is steadily improving.
Flat river: book value is relatively stable.
Falling river: book value is deteriorating.
The chart splits P/B into three bands: red, yellow and blue.
Based on the latest book value, the current price sits in the red band, meaning the share price is at a relatively high level.
The P/B river chart is VIP content
Unlock to see the last 5 years of the P/B river chart
VIP full research — unlimited tickers
Free reports today
of viewed today
This symbol is unlocked and counted toward today's quota
Reading on will use 1 of today's free views ( remaining)
Today's free views are used up; the allowance resets tomorrow
VIP unlocks
- Unlimited access to the factors and rules behind every stock/ETF four-light health check
- P/E and P/B valuation river charts
- Full sector health rankings and relative positioning
- Post-close LINE alerts for your watchlist
CBT (1595) Dividend policy
The latest ex-dividend date was 2026/09/23, distribution No.1 of 2026, paying a cash dividend of NT$0.467, a cash yield of 0.63%.Over the past five years the average cash dividend was NT$1.2, for an average cash yield of 3.01%.
| Year | Ex-date | Price before ex-date | Cash dividend | Payment date | Cash yield | Stock dividend |
|---|---|---|---|---|---|---|
CBT (1595) Institutional flows, margin & short
| Date | Foreign | Inv. Trust | Dealer | Total |
|---|---|---|---|---|
| Date | Margin balance (lots) | Short balance (lots) | Short/margin ratio (%) |
|---|---|---|---|
sector ranking
| Ticker | Health score | Close | Change | Volume | Turnover (100M) |
|---|---|---|---|---|---|
|
() (this stock) |
CBT (1595) — what it does
CBT (1595) full name: CBT, in the 半導體業 sector, with paid-in capital of 5.76 億 and a market cap of 34.99 億.
Founded on 1999/02/19, listed on the TPEx on 2011/10/04,
its principal business is 電子零組件製造業、設計、研發、生產CCD自動對位曝光機.
| Company | CBT Website | ||
|---|---|---|---|
| Chairman | 張鴻明 | President | 曾偉倫 |
| Founded | 1999/02/19 | TPEx listing date | 2011/10/04 |
| Industry | 半導體業 | Business tax ID | 16860440 |
| Address | 桃園市蘆竹區長興路三段277巷33號 | ||
| Main business | 電子零組件製造業、設計、研發、生產CCD自動對位曝光機 | ||
| Paid-in capital | 5.76 億 | ||
|---|---|---|---|
| Ordinary shares issued | 5,755.49 萬 shares | ||
| Market cap | 34.99 億 (2026/11/12) | ||
| Preferred shares | 0 shares | ||
| Auditor | 勤業眾信聯合會計師事務所 | ||
| Transfer agent | 福邦證券股份有限公司 | ||
Recommended brokerage accounts
如果想要開戶，目前新光證券的開戶好禮最多，新戶贈送證券期貨手續費折抵金 3000 元
也可以參考 Win投資證券開戶彙整 ，有更簡潔完善的資訊分享，包含特色、開戶禮等。
| 名稱 | 台股手續費 | 新戶禮 |
| 新光證券 (開戶點我) | 手續費 0 元 每月電子下單 100 萬以內 |
|
| 玉山證券 (開戶點我) | 2026 年 10 月起調降手續費率超低優惠。 詳 官網 | 新戶禮 $108 手續費回饋金 活動日期到 2027/9/30 |
| 國泰證券 (開戶點我) | 最低手續費 1 元 | 完成體驗登記+首筆成交回饋 300 元7-11數位商品卡券 2026/1/1~2026/12/31 |
| 口袋證券 (開戶點我) | 優惠價查詢 | 開立台股或台+美股送 $300 手續費折抵金 2026/10/1~12/31 |
(資料來源：各券商，最新資訊以各券商為主。資料整理：Win 投資)
My Watchlist
Sign in to build and track your own watchlist. Once you add symbols, you get a full closing report every day: health check, technical changes and a comparison against the TAIEX.